BeOne Medicines, Ltd. American Depositary Receipt (ONC)
NASDAQ
Real-time Data
01:30 PM
Day's Range
374.3752 wk Range
253.95Overview - ONC - BeOne Medicines, Ltd. American Depositary Receipt
Key Statistics
Valuation
Enterprise Value
39.52B
P/E (Trailing)
‪66.27‬
P/E (Forward)
‪36.41‬
PEG Ratio
‪0.51‬
Price / Sales (TTM)
‪6.91‬
Price / Book
‪8.17‬
EV / EBITDA
‪36.88‬
Profitability
Gross Margin
‪89.76%‬
Profit Margin
‪10.69%‬
Operating Margin
‪19.06%‬
Return on Assets
‪7.45%‬
Return on Equity
‪14.66%‬
Ownership
Shares Outstanding
1.46B
Float
80.95M
Short % of Shares Outstanding
‪1.09%‬
Held by Insiders
‪17.27%‬
Held by Institutions
‪33.12%‬
Price stats
Beta
‪0.50‬
50-Day Avg
‪311.89‬
200-Day Avg
‪316.49‬
Dividends
Payout Ratio
‪0.00%‬
Analyst Consensus
27 analysts
Average price target
‪$ 433.02‬Shariah Compliance
Report Date: Feb 19, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - ONC - BeOne Medicines, Ltd. American Depositary Receipt
Peers - ONC - BeOne Medicines, Ltd. American Depositary Receipt
Peer Comparison
Compared with companies in Biotechnology listed on NASDAQ.
- ONONCNASDAQBeOne Medicines, Ltd. American Depositary Receipt41.75BMarket Cap+16.20%52-week change64.85P/E (Trailing)‪10.69%‬Profit Margin
- ARGXNASDAQargenx SE American Depositary Receipt65.04BMarket Cap+34.86%52-week change39.69P/E (Trailing)‪32.26%‬Profit Margin
- ALNYNASDAQAlnylam Pharmaceuticals Inc31.60BMarket Cap-87.81%52-week change41.15P/E (Trailing)‪16.12%‬Profit Margin
- BNTXNASDAQBioNTech SE29.28BMarket Cap+9.87%52-week change160.80P/E (Trailing)‪-63.63%‬Profit Margin
- ASNDNASDAQAscendis Pharma A/S16.61BMarket Cap+24.84%52-week change19.38P/E (Trailing)‪70.84%‬Profit Margin
- BBIONASDAQBridgeBio Pharma, Inc.15.93BMarket Cap+41.98%52-week change-21.56P/E (Trailing)‪-97.02%‬Profit Margin
- BMRNNASDAQBiomarin Pharmaceutical Inc.12.91BMarket Cap+12.29%52-week change180.16P/E (Trailing)‪2.14%‬Profit Margin
Profile Summary - ONC - BeOne Medicines, Ltd. American Depositary Receipt
About
BeOne Medicines, Ltd. American Depositary Receipt represents ownership in BeOne Medicines Ltd., a Switzerland-domiciled global oncology company headquartered in Cambridge, Massachusetts with corporate operations there and primary offices in Basel, Switzerland. The company discovers, develops, and commercializes…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
